Project Oliver is ECD’s Bold Nod to the Urban SUV lifestyle, Melding Classic Defender Ethos with Modern Performance

KISSIMMEE, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design proudly introduces Project Oliver, a 1996 Land Rover Defender D110 Signature Edition that redefines modern adventure. Purpose-built from the ground up, this hand-crafted Defender merges raw capability with elevated luxury, offering a seamless blend of rugged performance and refined design. Every detail, from its […]

Project Oliver is ECD’s Bold Nod to the Urban SUV lifestyle, Melding Classic Defender Ethos with Modern Performance

Project Oliver is ECD's Bold Nod to the Urban SUV lifestyle, Melding Classic Defender Ethos with Modern Performance GlobeNewswire September 03, 2025 KISSIMMEE, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design proudly introduces Project Oliver, a 1996 Land Rover Defender D110 Signature Edition that redefines modern adventure. Purpose-built from the ground up, this

Meru Health validated by Validation Institute for significant healthcare savings

Meru Health, a leading virtual care provider transforming access to mental health treatment, today announced that its program has been independently validated by the Validation Institute for generating measurable healthcare cost savings. The validation confirms that Meru Health participants experience lower per-member per-month (PMPM) medical costs compared to matched non-participants. The Validation Institute, a trusted

symplr Compass Survey Spotlights Perpetual Crisis Culture Across Healthcare

Findings suggest clinicians are wasting even more time on administrative tasks as misalignment grows symplr®, a leading provider of enterprise healthcare operations software, today released findings from its fourth annual Compass Survey, which reveal that healthcare organizations remain entrenched in crisis culture. Clinicians report spending even more time on administrative work and that growing misalignment

Synchrony to Participate in the Barclays Global Financial Services Conference

Synchrony (NYSE:SYF) Chief Financial Officer, Brian J. Wenzel, will participate in a fireside chat at the Barclays Global Financial Services Conference on Wednesday, September 10, 2025 at 7:30 a.m. (Eastern Time). https://mma.prnewswire.com/media/804087/synchrony.jpg A live webcast and replay will be made available on the Synchrony Investor Relations website at www.investors.synchrony.com. About SynchronySynchrony (NYSE: SYF) is a

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright’s 27th Annual Global Investment Conference on Monday, September 8th

WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, or the “Company”), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., (“HOPE,” or the “Company”), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, today announced that Jonathan Javitt, M.D., M.P.H., Chairman and Chief Executive Officer of NRx Pharmaceuticals, will

Horizon Farm Credit Awards Over $136,000 to Support Agriculture, Education, and Community Development

Mechanicsburg, PA, Sept. 03, 2025 (GLOBE NEWSWIRE) — Through its Community Investment Grant program, Horizon Farm Credit awarded more than $136,000 in grants to 16 organizations throughout its 100-county footprint this summer. The grants fund initiatives focusing on agriculture innovation, agriculture education, diversity in agriculture, environmental stewardship, and strengthening communities. “At Farm Credit, we know

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright’s 27th Annual Global Investment Conference on Monday, September 8th

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th GlobeNewswire September 03, 2025 WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, or the “Company”), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., (“HOPE,” or the “Company”),

Horizon Farm Credit Awards Over $136,000 to Support Agriculture, Education, and Community Development

Horizon Farm Credit Awards Over $136,000 to Support Agriculture, Education, and Community Development Farm Credit's grant program awarded 16 organizations funding for initiatives that advance agriculture and build stronger communities. GlobeNewswire September 03, 2025 Mechanicsburg, PA, Sept. 03, 2025 (GLOBE NEWSWIRE) — Through its Community Investment Grant program, Horizon Farm Credit awarded more than $136,000

Alltrna Appoints David Hava, Ph.D., Chief Scientific Officer to Drive Strategic Pipeline Advancement of tRNA Medicines

Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA medicines to regulate the protein universe and resolve disease, today announced the appointment of David (Dave) Hava, Ph.D., as Chief Scientific Officer (CSO). Dr. Hava steps into the role previously held by Chris Henderson, Ph.D., who will become chairperson of Alltrna's Scientific

Scroll to Top